ATE194611T1 - Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung - Google Patents

Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung

Info

Publication number
ATE194611T1
ATE194611T1 AT94926387T AT94926387T ATE194611T1 AT E194611 T1 ATE194611 T1 AT E194611T1 AT 94926387 T AT94926387 T AT 94926387T AT 94926387 T AT94926387 T AT 94926387T AT E194611 T1 ATE194611 T1 AT E194611T1
Authority
AT
Austria
Prior art keywords
optically active
production
active imidazolidinone
same
imidazolidinone derivatives
Prior art date
Application number
AT94926387T
Other languages
English (en)
Inventor
Yasuo Takano
Kei Okazaki
Takashi - - - Sakurad Hirayama
Tsuyoshi Aza-Unoki Tomo Anraku
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE194611T1 publication Critical patent/ATE194611T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
AT94926387T 1993-09-17 1994-09-12 Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung ATE194611T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25498393 1993-09-17
JP24226494A JP3916093B2 (ja) 1993-09-17 1994-09-09 光学活性イミダゾリジノン誘導体とその製造方法
PCT/JP1994/001505 WO1995007905A1 (en) 1993-09-17 1994-09-12 Optically active imidazolidinone derivative and process for producing the same

Publications (1)

Publication Number Publication Date
ATE194611T1 true ATE194611T1 (de) 2000-07-15

Family

ID=26535688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94926387T ATE194611T1 (de) 1993-09-17 1994-09-12 Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung

Country Status (15)

Country Link
US (1) US5726188A (de)
EP (1) EP0719772B1 (de)
JP (1) JP3916093B2 (de)
KR (1) KR100323930B1 (de)
CN (1) CN1041088C (de)
AT (1) ATE194611T1 (de)
AU (1) AU679259B2 (de)
CA (1) CA2172162C (de)
DE (1) DE69425266T2 (de)
DK (1) DK0719772T3 (de)
ES (1) ES2149281T3 (de)
GR (1) GR3034499T3 (de)
HU (1) HU217668B (de)
PT (1) PT719772E (de)
WO (1) WO1995007905A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69407607T2 (de) * 1993-09-15 1998-08-06 Merck Sharp & Dohme Imidanolon- und oxanolonderivate als dopaminantagonisten
US6159990A (en) 1997-06-18 2000-12-12 Synaptic Pharmaceutical Corporation Oxazolidinones as α1A receptor antagonists
US6316623B1 (en) * 1998-08-21 2001-11-13 Isis Pharmaceuticals, Inc. Ethylenediamine compound libraries
CA2457647A1 (en) * 2001-10-02 2003-04-10 Acadia Pharmaceuticals, Inc. Benzimidazolidinone derivatives as muscarinic agents
US6951849B2 (en) * 2001-10-02 2005-10-04 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
EA016286B1 (ru) * 2005-09-30 2012-03-30 Глэксо Груп Лимитед Соединения, которые обладают активностью по отношению к рецепторам м, и их применения в медицине
JP5209479B2 (ja) * 2005-09-30 2013-06-12 グラクソ グループ リミテッド M1受容体にて活性を有するベンゾイミダゾロン類
JP5209481B2 (ja) * 2005-09-30 2013-06-12 グラクソ グループ リミテッド M1受容体にて活性を有する化合物および医薬におけるそれらの使用
WO2008102720A1 (ja) 2007-02-19 2008-08-28 Kaneka Corporation 光学活性3-アミノピペリジン又はその塩の製造方法
EP2457899A4 (de) * 2009-07-21 2015-06-03 Sumitomo Chemical Co Verfahren zur herstellung von optisch aktivem nipecotamid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196152A (en) * 1965-07-20 Phenyl and alkyleneamino substituted imidazolidinones and salts thereof
US459757A (en) * 1891-09-22 Electric-arc lamp
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
US3459757A (en) * 1965-10-22 1969-08-05 American Cyanamid Co Imidazolidines
US4011238A (en) * 1972-07-26 1977-03-08 Gruppo Lepetit S.P.A. 2-imidazolidione derivatives
GB9106571D0 (en) * 1991-03-27 1991-05-15 Erba Carlo Spa Derivatives of substituted imidazol-2-one and process for their preparation
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
DE69407607T2 (de) * 1993-09-15 1998-08-06 Merck Sharp & Dohme Imidanolon- und oxanolonderivate als dopaminantagonisten

Also Published As

Publication number Publication date
JP3916093B2 (ja) 2007-05-16
ES2149281T3 (es) 2000-11-01
DK0719772T3 (da) 2000-11-06
JPH07133273A (ja) 1995-05-23
EP0719772A1 (de) 1996-07-03
DE69425266T2 (de) 2001-02-22
CA2172162C (en) 2005-04-19
PT719772E (pt) 2000-11-30
EP0719772A4 (de) 1996-09-04
CN1041088C (zh) 1998-12-09
US5726188A (en) 1998-03-10
CA2172162A1 (en) 1995-03-23
HU9600622D0 (en) 1996-05-28
EP0719772B1 (de) 2000-07-12
AU679259B2 (en) 1997-06-26
GR3034499T3 (en) 2000-12-29
KR960704878A (ko) 1996-10-09
DE69425266D1 (de) 2000-08-17
HUT75649A (en) 1997-05-28
KR100323930B1 (ko) 2004-05-06
AU7624394A (en) 1995-04-03
HU217668B (hu) 2000-03-28
WO1995007905A1 (en) 1995-03-23
CN1135216A (zh) 1996-11-06

Similar Documents

Publication Publication Date Title
DE69332504D1 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
ATE139232T1 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
NO942452D0 (no) Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
ATE180780T1 (de) 2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
ATE201687T1 (de) Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament
DE69425266D1 (de) Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung
WO2002028853A1 (en) Benzylamine compound, process for producing the same, and intermediate therefor
DE69203426D1 (de) Oximderivate von Formylpyridylimidazolinone, deren herbizide Verwendung und Verfahren zu deren Herstellung.
AU7624494A (en) Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
NO941073L (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
ATE123493T1 (de) 3-(1h-indazol-3-yl)-4-pyridiname, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE180251T1 (de) Indan derivate und verfahren zu deren herstellung
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
ATE364600T1 (de) Verfahren zur herstellung von indol-derivaten und intermediaten dafür
ATE130002T1 (de) 1-(pyridinylalkyl)-1h-indole, -indoline und analoge.
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
EP1043320A4 (de) Neuartiges verfahren zur herstellung von aminopiperazinen
GB9614422D0 (en) Novel process
ATE239707T1 (de) 2-phenylpyridine-derivate und verfahren zu deren herstellung
EP1340753A4 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
TW328088B (en) Imidazolidinone derivative and its acid additional salt, for treatment of senile dementia and the process for preparing them
ATE135682T1 (de) 2-(3-phenylpropyl)hydrazine, verfahren zu ihrer herstellung, zwischenprodukte dafür und ihre verwendung als medikamente

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee